Annual Shareholders Equity
$25.97 B
+$3.31 B+14.60%
31 December 2023
Summary:
Regeneron Pharmaceuticals annual stockholders equity is currently $25.97 billion, with the most recent change of +$3.31 billion (+14.60%) on 31 December 2023. During the last 3 years, it has risen by +$14.95 billion (+135.58%). REGN annual shareholders equity is now at all-time high.REGN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$29.33 B
+$1.12 B+3.97%
30 September 2024
Summary:
Regeneron Pharmaceuticals quarterly stockholders equity is currently $29.33 billion, with the most recent change of +$1.12 billion (+3.97%) on 30 September 2024. Over the past year, it has increased by +$4.42 billion (+17.75%). REGN quarterly shareholders equity is now at all-time high.REGN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.6% | +17.8% |
| 3 y3 years | +135.6% | +69.9% |
| 5 y5 years | +196.6% | +179.2% |
REGN Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +135.6% | at high | +69.9% |
| 5 y | 5 years | at high | +196.6% | at high | +223.8% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Regeneron Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.33 B(+4.0%) |
| June 2024 | - | $28.21 B(+4.5%) |
| Mar 2024 | - | $26.99 B(+3.9%) |
| Dec 2023 | $25.97 B(+14.6%) | $25.97 B(+4.3%) |
| Sept 2023 | - | $24.90 B(+3.7%) |
| June 2023 | - | $24.02 B(+2.2%) |
| Mar 2023 | - | $23.50 B(+3.7%) |
| Dec 2022 | $22.66 B(+20.8%) | $22.66 B(+5.7%) |
| Sept 2022 | - | $21.44 B(+3.6%) |
| June 2022 | - | $20.69 B(+3.9%) |
| Mar 2022 | - | $19.91 B(+6.1%) |
| Dec 2021 | $18.77 B(+70.2%) | $18.77 B(+8.8%) |
| Sept 2021 | - | $17.26 B(+14.1%) |
| June 2021 | - | $15.13 B(+26.3%) |
| Mar 2021 | - | $11.98 B(+8.6%) |
| Dec 2020 | $11.03 B(-0.6%) | $11.03 B(+8.9%) |
| Sept 2020 | - | $10.13 B(+11.8%) |
| June 2020 | - | $9.06 B(-25.3%) |
| Mar 2020 | - | $12.13 B(+9.4%) |
| Dec 2019 | $11.09 B(+26.6%) | $11.09 B(+5.6%) |
| Sept 2019 | - | $10.50 B(+7.7%) |
| June 2019 | - | $9.76 B(+3.3%) |
| Mar 2019 | - | $9.44 B(+7.8%) |
| Dec 2018 | $8.76 B(+42.5%) | $8.76 B(+11.3%) |
| Sept 2018 | - | $7.87 B(+9.5%) |
| June 2018 | - | $7.19 B(+9.4%) |
| Mar 2018 | - | $6.57 B(+6.9%) |
| Dec 2017 | $6.14 B(+38.1%) | $6.14 B(+1.5%) |
| Sept 2017 | - | $6.05 B(+9.6%) |
| June 2017 | - | $5.52 B(+13.5%) |
| Mar 2017 | - | $4.87 B(+9.4%) |
| Dec 2016 | $4.45 B(+21.7%) | $4.45 B(-0.9%) |
| Sept 2016 | - | $4.49 B(+10.2%) |
| June 2016 | - | $4.08 B(+8.3%) |
| Mar 2016 | - | $3.77 B(+3.0%) |
| Dec 2015 | $3.65 B(+43.3%) | $3.65 B(+10.9%) |
| Sept 2015 | - | $3.30 B(-1.2%) |
| June 2015 | - | $3.34 B(+12.4%) |
| Mar 2015 | - | $2.97 B(+16.5%) |
| Dec 2014 | $2.55 B(+30.6%) | $2.55 B(-0.1%) |
| Sept 2014 | - | $2.55 B(+7.7%) |
| June 2014 | - | $2.37 B(+7.1%) |
| Mar 2014 | - | $2.21 B(+13.3%) |
| Dec 2013 | $1.95 B(+56.7%) | $1.95 B(+15.5%) |
| Sept 2013 | - | $1.69 B(+13.2%) |
| June 2013 | - | $1.49 B(+6.2%) |
| Mar 2013 | - | $1.41 B(+12.9%) |
| Dec 2012 | $1.25 B(+156.4%) | $1.25 B(+54.5%) |
| Sept 2012 | - | $806.02 M(+35.5%) |
| June 2012 | - | $594.66 M(+18.0%) |
| Mar 2012 | - | $504.02 M(+3.8%) |
| Dec 2011 | $485.73 M(-8.0%) | $485.73 M(+13.4%) |
| Sept 2011 | - | $428.25 M(-10.4%) |
| June 2011 | - | $478.03 M(-7.7%) |
| Mar 2011 | - | $518.09 M(-1.8%) |
| Dec 2010 | $527.82 M(+33.0%) | $527.82 M(+51.6%) |
| Sept 2010 | - | $348.06 M(-6.2%) |
| June 2010 | - | $371.22 M(-3.9%) |
| Mar 2010 | - | $386.27 M(-2.6%) |
| Dec 2009 | $396.76 M(-5.9%) | $396.76 M(-6.1%) |
| Sept 2009 | - | $422.44 M(+2.9%) |
| June 2009 | - | $410.51 M(+0.0%) |
| Mar 2009 | - | $410.32 M(-2.7%) |
| Dec 2008 | $421.51 M(-8.4%) | $421.51 M(-3.5%) |
| Sept 2008 | - | $436.93 M(-3.1%) |
| June 2008 | - | $451.00 M(-2.1%) |
| Mar 2008 | - | $460.60 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $460.27 M(+112.5%) | $460.27 M(+204.0%) |
| Sept 2007 | - | $151.40 M(-15.6%) |
| June 2007 | - | $179.34 M(-8.8%) |
| Mar 2007 | - | $196.69 M(-9.2%) |
| Dec 2006 | $216.62 M(+90.0%) | $216.62 M(+246.7%) |
| Sept 2006 | - | $62.47 M(-25.4%) |
| June 2006 | - | $83.77 M(-18.1%) |
| Mar 2006 | - | $102.32 M(-10.2%) |
| Dec 2005 | $114.00 M(-37.5%) | $114.00 M(-16.4%) |
| Sept 2005 | - | $136.38 M(-17.4%) |
| June 2005 | - | $165.06 M(-11.2%) |
| Mar 2005 | - | $185.78 M(+1.8%) |
| Dec 2004 | $182.54 M(+32.6%) | $182.54 M(+2.1%) |
| Sept 2004 | - | $178.87 M(-5.9%) |
| June 2004 | - | $190.13 M(-6.8%) |
| Mar 2004 | - | $204.11 M(+48.3%) |
| Dec 2003 | $137.64 M(-5.7%) | $137.64 M(-11.9%) |
| Sept 2003 | - | $156.20 M(+13.3%) |
| June 2003 | - | $137.84 M(-16.8%) |
| Mar 2003 | - | $165.62 M(+13.4%) |
| Dec 2002 | $145.98 M(-45.2%) | $145.98 M(-19.3%) |
| Sept 2002 | - | $180.79 M(-15.2%) |
| June 2002 | - | $213.16 M(-12.1%) |
| Mar 2002 | - | $242.48 M(-9.0%) |
| Dec 2001 | $266.36 M(+46.2%) | $266.36 M(-9.7%) |
| Sept 2001 | - | $294.87 M(-5.9%) |
| June 2001 | - | $313.29 M(-3.4%) |
| Mar 2001 | - | $324.41 M(+78.1%) |
| Dec 2000 | $182.13 M(+66.3%) | $182.13 M(-4.6%) |
| Sept 2000 | - | $190.97 M(+8.5%) |
| June 2000 | - | $175.97 M(+66.6%) |
| Mar 2000 | - | $105.59 M(-3.6%) |
| Dec 1999 | $109.50 M(-16.5%) | $109.50 M(-0.9%) |
| Sept 1999 | - | $110.50 M(-4.2%) |
| June 1999 | - | $115.40 M(-6.5%) |
| Mar 1999 | - | $123.40 M(-5.9%) |
| Dec 1998 | $131.20 M(-5.5%) | $131.20 M(-4.2%) |
| Sept 1998 | - | $136.90 M(-0.7%) |
| June 1998 | - | $137.80 M(+1.8%) |
| Mar 1998 | - | $135.40 M(-2.5%) |
| Dec 1997 | $138.90 M(+29.9%) | $138.90 M(+0.5%) |
| Sept 1997 | - | $138.20 M(-1.2%) |
| June 1997 | - | $139.90 M(+38.5%) |
| Mar 1997 | - | $101.00 M(-5.5%) |
| Dec 1996 | $106.90 M(+57.4%) | $106.90 M(+2.6%) |
| Sept 1996 | - | $104.20 M(-7.6%) |
| June 1996 | - | $112.80 M(+81.6%) |
| Mar 1996 | - | $62.10 M(-8.5%) |
| Dec 1995 | $67.90 M(+1.2%) | $67.90 M(+28.1%) |
| Sept 1995 | - | $53.00 M(-10.8%) |
| June 1995 | - | $59.40 M(-6.9%) |
| Mar 1995 | - | $63.80 M(-4.9%) |
| Dec 1994 | $67.10 M(-31.8%) | $67.10 M(-7.8%) |
| Sept 1994 | - | $72.80 M(-5.0%) |
| June 1994 | - | $76.60 M(-11.6%) |
| Mar 1994 | - | $86.70 M(-11.9%) |
| Dec 1993 | $98.40 M(+12.8%) | $98.40 M(-10.6%) |
| Sept 1993 | - | $110.10 M(+61.0%) |
| June 1993 | - | $68.40 M(-12.1%) |
| Mar 1993 | - | $77.80 M(-10.8%) |
| Dec 1992 | $87.20 M(-17.9%) | $87.20 M(-6.7%) |
| Sept 1992 | - | $93.50 M(-5.8%) |
| June 1992 | - | $99.30 M(-3.6%) |
| Mar 1992 | - | $103.00 M(-3.0%) |
| Dec 1991 | $106.20 M(+770.5%) | $106.20 M(-2.0%) |
| Sept 1991 | - | $108.40 M(-0.8%) |
| June 1991 | - | $109.30 M(+795.9%) |
| Dec 1990 | $12.20 M | $12.20 M |
FAQ
- What is Regeneron Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual shareholders equity year-on-year change?
- What is Regeneron Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Regeneron Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of REGN is $25.97 B
What is the all time high annual shareholders equity for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual stockholders equity is $25.97 B
What is Regeneron Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, REGN annual stockholders equity has changed by +$3.31 B (+14.60%)
What is Regeneron Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of REGN is $29.33 B
What is the all time high quarterly shareholders equity for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly stockholders equity is $29.33 B
What is Regeneron Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, REGN quarterly stockholders equity has changed by +$4.42 B (+17.75%)